Alpha Tau Medical (DRTS) Total Liabilities (2020 - 2026)
Alpha Tau Medical (DRTS) posted Total Liabilities of $39.4 million for Q1 2026, up 38.06% sequentially from $28.6 million in Q4 2025, and up 60.23% YoY from $24.6 million in Q1 2025.
Alpha Tau Medical (DRTS) Total Liabilities (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Total Liabilities for 7 years, with the latest figure at $39.4 million in Q1 2026.
- Quarterly Total Liabilities rose 60.23% year-over-year to $39.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.4 million (up 60.23% YoY) and the FY2025 annual result came in at $28.6 million, up 21.31% from the prior year.
- Total Liabilities climbed to $39.4 million in Q1 2026 per DRTS's latest filing, from $28.6 million in the prior quarter.
- Over five years, Total Liabilities peaked at $39.4 million in Q1 2026 and troughed at $12.1 million in Q3 2022.
- A 5-year average of $22.2 million and a median of $22.9 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Liabilities plunged 37.07% in 2022, then soared 60.23% in 2026.
- Over 5 years, Total Liabilities stood at $14.5 million in 2022, then surged by 58.11% to $22.9 million in 2023, then rose by 2.73% to $23.5 million in 2024, then grew by 21.31% to $28.6 million in 2025, then soared by 38.06% to $39.4 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $39.4 million, $28.6 million, and $27.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | 90.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 90.20 Mn |
| Mar 31, 2026 | 39.42 Mn |
| Dec 31, 2025 | 28.55 Mn |
| Sep 30, 2025 | 27.11 Mn |
| Jun 30, 2025 | 24.33 Mn |
| Mar 31, 2025 | 24.60 Mn |
| Dec 31, 2024 | 23.54 Mn |
| Sep 30, 2024 | 21.33 Mn |
| Jun 30, 2024 | 22.03 Mn |
| Mar 31, 2024 | 23.38 Mn |
| Dec 31, 2023 | 22.91 Mn |
| Sep 30, 2023 | 16.89 Mn |
| Jun 30, 2023 | 18.64 Mn |
| Mar 31, 2023 | 16.88 Mn |
| Dec 31, 2022 | 14.49 Mn |
| Sep 30, 2022 | 12.11 Mn |
| Jun 30, 2022 | 15.71 Mn |
| Mar 31, 2022 | 25.05 Mn |
| Dec 31, 2021 | 23.03 Mn |
| Dec 31, 2020 | 7.45 Mn |